Global Cancer Supportive Care Market is expected to grow at the CAGR of 4.24% during 2017-2025

According to a recently published report by Brisk Insights, the Global Cancer Supportive Care Market is expected to grow at the CAGR of 4.24% during 2017-2025. The global cancer supportive care market is segmented on the basis of products, applications and geography. The report on global cancer supportive care market (by therapeutic area, cancer type, sales channel and geography) provides a detailed overview and predictive analysis of the market.

Full report available on Cancer Supportive Care Market: Global Industry Size, Growth, Share and Forecast to 2025 report at http://www.briskinsights.com/report/cancer-supportive-care-market

Market Insights

As the global prevalence of cancer is continuously growing, there has been a corresponding rise in methods of cancer care, which has led to evolution of treatments like radiation therapy and chemotherapy. However, evolution of such cytotoxic treatments has also brought with itself a host of side effects that greatly interfere with the overall treatment outcome and patient wellbeing. This phenomenon has led to emergence of supportive acre drugs that assist in controlling and managing debilitating side effects such as anemia, neutropenia, nausea and vomiting etc.

Perpetual growth in incidence of cancer is observed to be the major driver of cancer supportive care market. Furthermore, introduction of novel and more potent cancer drugs has presented with them a range of side effects that interfere with seamless treatment management and overall patient wellbeing. Other factors such as growth in awareness among both patients and healthcare staff and evolving reimbursement system will open further opportunities in this market.

Scope of the report

1. Global Cancer Supportive Care Market, by Therapeutic Area, 2015–2025 ($ Millon)

1.1. Oral mucositis and dry mouth
1.2. Chemotherapy induced nausea and vomiting
1.3. Cancer Pain
1.4. Chemotherapy Induced Anemia
1.5. Chemotherapy Induced Neutropenia
1.6. Bone Metastases

2. Global Cancer Supportive Care Market, by Cancer Type, 2015–2025 ($ Millon)

2.1. Lung Cancer
2.2. Liver Cancer
2.3. Breast Cancer
2.4. Leukemia
2.5. Prostate Cancer
2.6. Ovarian Cancer
2.7. Bladder Cancer
2.8. Others

3. Global Cancer Supportive Care Market, by Sales Channel, 2015–2025 ($ Millon)

3.1. Hospital Pharmacies
3.2. Retail Pharmacies
3.3. Compounding Pharmacies

4. Global Cancer Supportive Care Market, by Geography, 2015-2025 ($ Millon)

4.1. North America 
4.1.1. U.S.
4.1.2. Canada
4.2. Europe 
4.2.1. U.K.
4.2.2. Germany
4.2.3. France
4.2.4. Rest of Europe
4.3. Asia Pacific 
4.3.1. Japan
4.3.2. China
4.3.3. Rest of Asia Pacific
4.4. Latin America (LATAM)
4.4.1. Brazil
4.4.2. Mexico
4.4.3. Rest of Latin America
4.5. Middle East and Africa (MEA)
4.5.1. Saudi Arabia
4.5.2. South Africa
4.5.3. Rest of Middle East and Africa

5. Company Profiles

5.1. Amgen Inc.
5.2. Novartis AG
5.3. Johnson & Johnson
5.4. Pfizer
5.5. Teva Pharmaceutical Industries Ltd.
5.6. F. Hoffmann-La Roche Ltd.
5.7. Baxter International Inc.
5.8. Fagron Group BV
5.9. Helsinn Group
5.10. Acacia Pharma Ltd.
5.11. Other Major Players

Request Sample: http://www.briskinsights.com/sample-request/561

About Us

Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to  aid businesses identify market opportunities optimize strategies. Our team of 200 analysts’ provides enterprises with strategic insights. Brisk Insights works to help enterprises grow through strategic insights and actionable solutions

Contact Us: 

Office 1094

109 Vernon House

Friar Lane

Nottingham

NG1 6DQ

+448081890034 (UK)

sales@briskinsights.com